# OnCo record paper-luca-gianni-cancer-med-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-luca-gianni-cancer-med-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-luca-gianni-cancer-med-2023" ;
  schema:name "Phase II study (KAMELEON) of single-agent T-DM1 in patients with HER2-positive advanced urothelial bladder cancer or pancreatic cancer/cholangiocarcinoma"@en ;
  schema:description "Paper by Luca Gianni indexed on Europe PMC as PubMed record 37119523, in Cancer medicine (2023), one of the most cited records naming an author with this name at Fondazione Michelangelo."@en ;
  schema:url <https://onco.cc/key-papers/paper-luca-gianni-cancer-med-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1002/cam4.5893>, <https://pubmed.ncbi.nlm.nih.gov/37119523/>, <https://europepmc.org/article/MED/37119523> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1002/cam4.5893> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "de Vries EGE, Rüschoff J, Lolkema M, et al." ;
  onco:people <https://onco.cc/people/luca-gianni/> ;
  onco:journals <https://onco.cc/journals/cancer-medicine/> .